|Tazan Company Profile – Lifeplus|
|About Company||Target Market/ Customers||Products/Solutions|
|One in three adults who suffer from multiple Chronic Conditions||Non-invasive glucose and blood pressure monitoring smart watch|
|Number of Employees:
Major Health Care Provider in South East Asia
| Unique Strengths:
Non-invasive, Clinical Grade. FDA approval expected in 2021.
|Awards and Recognition:|